Vida Ventures logo

Vida Ventures

North America, Massachusetts, United States, Boston

Description

Vida Ventures is a next-generation life sciences investment firm .

Investor Profile

Vida Ventures has made 55 investments, with 6 in the past 12 months and 38% as lead.

Stage Focus

  • Series A (38%)
  • Series B (29%)
  • Series C (11%)
  • Seed (9%)
  • Private Equity (4%)
  • Series E (4%)
  • Series D (2%)
  • Series Unknown (2%)
  • Post Ipo Equity (2%)

Country Focus

  • United States (93%)
  • China (2%)
  • The Netherlands (2%)
  • India (2%)
  • France (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Oncology
  • Precision Medicine
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Vida Ventures frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 12
OrbiMed
North America, New York, United States, New York
Co-Investments: 17
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 11
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 7
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 13
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 8
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 11
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 10
Invus
North America, New York, United States, New York
Co-Investments: 8
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 8

Which angels does Vida Ventures often collaborate with?

SH
North America, North Carolina, United States, Raleigh
Shared Deals: 1
JT
North America, California, United States, San Francisco
Shared Deals: 1
AB
North America, California, United States, Los Angeles
Shared Deals: 1
TA
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
RP
North America, California, United States, San Francisco
Shared Deals: 1
NB
North America, California, United States, San Mateo
Shared Deals: 2
JF
North America, California, United States
Shared Deals: 1
Shared Deals: 1
Anshumani Ruddra
Asia, Karnataka, India, Bangalore
Shared Deals: 1

What are some of recent deals done by Vida Ventures?

Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics
Series ASep 9, 2024
Amount Raised: $370,000,000
Halda Therapeutics

New Haven, Connecticut, United States

Halda Therapeutics is a research-stage drug discovery company.

BiotechnologyMedicalTherapeutics
Series BAug 12, 2024
Amount Raised: $126,000,000
Third Arc Bio

Boston, Massachusetts, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

BiotechnologyHealth CareLife ScienceMedicalOncology
Series AJul 23, 2024
Amount Raised: $165,000,000
Scorpion Therapeutics

Boston, Massachusetts, United States

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine
Series CJul 16, 2024
Amount Raised: $150,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityJun 20, 2024
Amount Raised: $130,700,000
InduPro

Seattle, Washington, United States

InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies.

BiotechnologyMedicalTherapeutics
Series AJun 13, 2024
Amount Raised: $85,000,000
Alterome Therapeutics

San Diego, California, United States

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

BiopharmaBiotechnologyPharmaceutical
Series BApr 3, 2024
Amount Raised: $132,000,000
Capstan Therapeutics

San Diego, California, United States

Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.

BiotechnologyHealth CareTherapeutics
Series BMar 20, 2024
Amount Raised: $175,000,000
Avalyn Pharma

Seattle, Washington, United States

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

BiopharmaBiotechnologyMedicalPharmaceutical
Series CSep 27, 2023
Amount Raised: $175,000,000
ReCode Therapeutics

Dallas, Texas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

BiopharmaBiotechnologyGeneticsPharmaceutical
Series BSep 19, 2023
Amount Raised: $50,000,000